Small and mid-cap stocks are in correction mode after posting one of their best July's ever. MapSignals' Alec Young lays out how to play the space. Plus, RXO says a soft freight market is weighing on revenue. CEO Drew Wilkerson explains. And, Eli Lilly reports results today after rival Novo Nordisk warned of pricing pressures in the weight-loss drug industry. Tema ETFs' Maurits Pot discusses the outlook. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios